Research Institute of Molecular Pathology

Error creating thumbnail:

The Research Institute of Molecular Pathology (IMP) is a renowned biomedical research institute located in Vienna, Austria. It is dedicated to the study of molecular biology, genetics, and biochemistry with a focus on understanding the fundamental mechanisms of life at the molecular level.

History

The IMP was founded in 1985 as a joint initiative between the pharmaceutical company Boehringer Ingelheim and the Austrian Academy of Sciences. The institute was established to foster cutting-edge research in molecular biology and to contribute to the scientific community through high-impact publications and collaborations.

Research Areas

The research at IMP covers a wide range of topics within molecular biology, including but not limited to:

• Cell biology
• Developmental biology
• Neuroscience
• Structural biology
• Genomics
• Epigenetics
• Cancer research

Facilities

The IMP is equipped with state-of-the-art facilities that support advanced research in molecular biology. These include:

• Core facilities for microscopy, mass spectrometry, and next-generation sequencing
• Animal facility for model organism research
• Bioinformatics support for data analysis

Collaborations

The IMP collaborates with numerous academic institutions and research organizations worldwide. It is part of the Vienna Biocenter, a leading life sciences cluster that includes other research institutes such as the Institute of Molecular Biotechnology (IMBA) and the Gregor Mendel Institute (GMI).

Education and Training

The IMP is committed to training the next generation of scientists. It offers various educational programs, including:

• PhD programs in collaboration with the University of Vienna and the Medical University of Vienna
• Postdoctoral fellowships
• Summer schools and workshops

Achievements

Researchers at the IMP have made significant contributions to the field of molecular biology, including groundbreaking discoveries in gene regulation, protein structure, and cell signaling. The institute has a strong publication record in high-impact scientific journals.

See Also

• Vienna Biocenter
• Institute of Molecular Biotechnology
• Gregor Mendel Institute
• Austrian Academy of Sciences
• Boehringer Ingelheim